The Porcupine Inhibitor AZD5055 Inhibits Wnt Palmitoylation and Release, and Has Potential to Repair Damaged Alveoli Through Increasing Type 1 Alveolar Epithelial Cell Numbers

被引：0

作者：

Overed-Sayer, C. ^{[1
]}

Karim, L. ^{[1
]}

McElroy, A. ^{[1
]}

Nishimoto, S. ^{[1
]}

Moldobaeva, A. ^{[2
]}

Clark, S. ^{[2
]}

Ghaedi, M. ^{[2
]}

Grime, K. ^{[3
]}

Hornberg, E. ^{[4
]}

机构：

[1] AstraZeneca, Biosci COPD IPF Res & Early Dev Resp & Immunol, Cambridge, England

[2] AstraZeneca, Biosci COPD IPF Res & Early Dev Resp & Immunol, Gaithersburg, MD USA

[3] AstraZeneca, Biosci COPD IPF Res & Early Dev Resp & Immunol, Molndal, Sweden

[4] AstraZeneca, Projects Res & Early Dev Resp & Immunol, Molndal, Sweden

来源：

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A2177

引用

页数：1